Home - Products - Others - Other Targets - (-)-5-Isopropyl-2-Methyl-13-Cyclohexadiene

(-)-5-Isopropyl-2-Methyl-13-Cyclohexadiene

CAS No. 4221-98-1

(-)-5-Isopropyl-2-Methyl-13-Cyclohexadiene( (R)-(-)-α-Phellandrene )

Catalog No. M21502 CAS No. 4221-98-1

(-)-5-Isopropyl-2-Methyl-13-Cyclohexadiene is a natural compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 207 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (-)-5-Isopropyl-2-Methyl-13-Cyclohexadiene
  • Note
    Research use only, not for human use.
  • Brief Description
    (-)-5-Isopropyl-2-Methyl-13-Cyclohexadiene is a natural compound.
  • Description
    (-)-5-Isopropyl-2-Methyl-13-Cyclohexadiene is a natural compound.
  • In Vitro
    (R)-(-)-α-Phellandrene shows weak inhibitory activities against bacteria including MRSA, A. tumefaciens, E. carotovora subsp. Carotovora (MIC: 2 mg/mL).
  • In Vivo
    ——
  • Synonyms
    (R)-(-)-α-Phellandrene
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4221-98-1
  • Formula Weight
    136.23
  • Molecular Formula
    C10H16
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)[C@@H]1C=CC(C)=CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • [Sar1, Ile8]-Angiote...

    [Sar1, Ile8]-Angiotensin II (TFA) is a peptide that has multiple effects on vascular smooth muscle, including contraction of normal arteries and hypertrophy or hyperplasia of cultured cells or diseased vessels.

  • Methyl lucidenate C

    Methyl lucidenate C

  • Stressin I

    Potent and selective corticotropin releasing factor receptor-1 (CRF1) agonist (Ki values are 1.5 and 224 nM for CRF1 and CRF2 receptors respectively). Increases ACTH levels and increases faecal pellet output in vivo following i.p. administration.